3 Houston innovators to know this week

Who's who

From fitness tech and interior design to super thin wearable technology, this week's innovators to know can't be stopped. Courtesy photos

Another week, another set of Houston innovators to keep your eye on. This week's cast of characters are from across industries — from fitness innovation to interior design for tech companies. Scroll through to meet the people behind Houston innovation.

Lizzie DeLacy, founder of DeLacy Wellness

Photo courtesy of DeLacy Wellness

After years of working in fitness, Lizzie DeLacy, founder of DeLacy Wellness, wanted to be able to help more people on their health and wellness journeys. She launched Bodypeace — an app that offers workout sessions, recipes, and tips for a healthier lifestyle — to help people make time for fitness and mindfulness.

"Rather than focusing on really long sessions, though we have a couple in there, we focus on short 5-minute sessions, so anyone can fit movement into their schedule and lifestyle," DeLacy tells InnovationMap. "Additionally, we break it down by body part focus, because oftentimes people don't know necessarily what exact movement or pose or stretch they might need."

Cunjiang Yu, a Bill D. Cook associate professor of Mechanical Engineering at the University of Houston

Photo courtesy of UH

Cunjiang Yu, a professor and researcher at the University of Houston, is the lead author on a paper that ran as the cover story in Science Advances. In the paper, Yu identifies a wearable technology that can detect health conditions while being so incredibly thin, the wearer might not even notice.

"Everything is very thin, just a few microns thick," says Yu, who also is a principal investigator at the Texas Center for Superconductivity at UH, in a release. "You will not be able to feel it."

Amy English, director of interiors for HOK

Photo courtesy of HOK

For most people, the design of an office might be non-consequential. But, for Amy English, director if interiors for HOK, designing the right space can do wonders for your company. English wrote a guest article for InnovationMap that outlines different trends in interior design for tech companies.

"While the next big technological advancement isn't set in stone, one thing is certain: Companies that wish to remain competitive and responsive in the future will need workplaces with the flexibility and personalization that allow their people to gather, connect, innovate, and simply be their best," she writes.

Read English's guest article here.

Lizzie DeLacy, founder of DeLacy Wellness, launched a new platform called Bodypeace offering wellness and exercise tips through the app. Courtesy of DeLacy Wellness

Houston fitness guru takes her expertise mobile with new app

Fit tech

As time spent on mobile devices stretches longer and attention spans get shorter, a Houstonian thinks she has a solution to combine personal technology and a healthy lifestyle.

Lizzie DeLacy, founder of DeLacy Wellness, has launched a new app called Bodypeace that offers workout sessions, recipes, and tips for a healthier lifestyle, but in a different way than consumers might be used to.

"Rather than focusing on really long sessions, though we have a couple in there, we focus on short 5 minute sessions, so anyone can fit movement into their schedule and lifestyle," DeLacy tells InnovationMap. "Additionally, we break it down by body part focus, because oftentimes people don't know necessarily what exact movement or pose or stretch they might need."

DeLacy worked as a private fitness instructor for years before deciding to create the Bodypeace app to make her coaching and practices accessible to more people. Her goal is to help as many people as possible feel better so they can grow to be the best version of themselves, referring to this concept as "Eventual Energy."

The Bodypeace app, which launched on iTunes and Google Play on July 17, allows users to filter by body part, choosing between an all body session, or focus on a specific spot such as hamstrings, hips, back, shoulders, and more.

"In my experience as a yoga instructor, I saw that these are pain points for a lot of people," says DeLacy.

The app tailors content for the user by asking a series of questions about workout habits, and lifestyle. There is a free trial period for users to explore the app, as well as paid options, $17.99 a month or $119.99 a year.

"The busier people get the less they want to spend time in their cars or pay the fees that are associated with gym memberships, and having the ability to do something from the comfort of your own home or on demand that fits your schedule," says DeLacy. "I think it's really appealing to a lot of people, myself included."

DeLacy shares that many fitness apps out there geared towards getting a six pack or losing weight can be intimidating to those that have never worked out before or have an injury that they're recovering from. She designed her app to be accessible for all fitness levels, ages, and genders.

"The content on Bodypeace is really for the athletes and the 'never-evers' alike," DeLacy tells InnovationMap. "There is a whole group of people that are either new to working out or have never considered it before."

DeLacy founded DeLacy Wellness in 2016, a year after she moved to Houston. DeLacy is a certified yoga instructor and holds a health coaching certification. The company, which is privately funded, has two full-time staff, DeLacy and her partner and COO Jack Martin, two advisory board members, two instructors, and one community contributor.

DeLacy tells InnovationMap that on the community portion of the Bodypeace app, there is a lot of free information available for users to test the content. DeLacy and her team hope to connect wellness content creators and contributors with people who are looking for information to feel and live better.

"We're hoping to create a platform where you're doing movement and you're also going to learn about movement, nutrition, mental health, and other topics dealing with wellness," says DeLacy.

Ad Placement 300x100

Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings

INNOVATIONMAP EMAILS ARE AWESOME